2,5-Dimethyl-4-methoxyphenylboronic acid, 95.0%, 5g

HPLC column NUCLEODUR® NH2-RP 3 µm, 250 mm, 1 Piece(s)

3,4-Dihydro-2H-pyrano[2,3-b]pyridine, 97%, 1g

(2S,4R)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide, 97%, 1g

2'-(Trifluoromethyl)acetophenone>98.0%(GC)5g

(5aR,10bS)-2-(2,4,6-Trichlorophenyl)-4,5a,6,10b-tetrahydroindeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-2-ium tetrafluoroborate, 97%, 1g

tert-Butyl spiro[indene-1,4'-piperidine]-1'-carboxylate, 95.0%, 250mg

Arachidic acid methyl ester, 99.0%, 5g

((4-chloro-3-(trifluoromethyl)phenyl)sulfonyl)proline, 95.0%, 500mg

CIS-2-METHYLCYCLOPROPANECARBOXYLIC ACID, 95.0%, 5g

3,4-Dichloro-5-methoxy-pyridazine, 97%, 250mg

4-Methoxyphenol>99.0%(GC)500g

methyl 4-(2-hydroxyphenyl)-2,4-dioxobutanoate, 250mg